Post Traumatic Stress Disorder (PTSD) Clinical Trial
Official title:
Psychometric Properties of the International Trauma Interview (ITI) for ICD-11 PTSD and CPTSD
Verified date | November 2022 |
Source | University of Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the project is to evaluate the psychometric properties (e.g. validity, reliability) of the International Trauma Interview (ITI) - German version. The ITI is a structured clinical interview that corresponds to the ICD-11 criteria for diagnosing both posttraumatic stress disorder (PTSD) and complex posttraumatic stress disorder (CPTSD). Eligible participants from psychiatric inpatient and outpatient facilities in Switzerland who have provided informed will complete various self-report measures about trauma-related mental health complaints. In addition, the ITI will be conducted by a trained clinician. Lastly, information from the medical chart will be further used for scientific purpose. The overall assessment will take approximately 1-2 hours to complete.
Status | Completed |
Enrollment | 77 |
Est. completion date | October 15, 2021 |
Est. primary completion date | October 15, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility | Study-specific Inclusion criteria - Structured diagnostic procedures upon hospital entry not yet started, except for orienting assessments - Able to give informed consent as documented by signature - Able to understand and communicate in German Exclusion criteria - Clinical signs for impaired cognitive abilities - Other contraindications to undergo the clinical interview |
Country | Name | City | State |
---|---|---|---|
Switzerland | Integrierte Psychiatrie Winterthur, Spezialstation für Traumafolgestörungen | Winterthur | Zurich |
Lead Sponsor | Collaborator |
---|---|
University of Zurich |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | International Trauma Interview (ITI) | Up to two weeks upon psychiatric ward entry | ||
Primary | Life Event Checklist DSM-5 | Up to two weeks upon psychiatric ward entry | ||
Secondary | Beck Depression Inventory II | Up to seven days upon psychiatric ward entry | ||
Secondary | Brief Symptom Checklist | Up to seven days upon psychiatric ward entry | ||
Secondary | Impact of Event Scale Revised Version | Up to seven days upon psychiatric ward entry | ||
Secondary | PTSD Checklist for DSM-5 | Up to seven days upon psychiatric ward entry | ||
Secondary | Borderline Symptom List | Up to seven days upon psychiatric ward entry |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00554177 -
A Clinical Trial for Post Traumatic Stress Disorder
|
Phase 1 | |
Recruiting |
NCT01545505 -
Identification of Markers of Post-Traumatic Stress Disorder (PTSD) Relapse
|
N/A | |
Completed |
NCT02966873 -
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
|
Phase 2 | |
Completed |
NCT04827056 -
Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
|
Phase 1 | |
Completed |
NCT04073862 -
The Norwegian Stepped-Care TF-CBT Study
|
N/A | |
Recruiting |
NCT05254379 -
Transcranial Direct Current Stimulation Treatment for Warriors Experiencing Chronic Pain
|
N/A | |
Terminated |
NCT02077972 -
Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT02723097 -
A Pilot Test of the Relaxation Response Resiliency Program (3RP) in Spanish Speaking World Trade Center Survivors With Post Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT01629537 -
A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder
|
Phase 2 | |
Withdrawn |
NCT00641511 -
Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)
|
Phase 2 | |
Recruiting |
NCT04558437 -
COVID-Impact "Psychological IMPACT of Covid-19 on AP-HP Staff"
|
||
Not yet recruiting |
NCT06162741 -
Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans
|
N/A | |
Completed |
NCT02764983 -
Occupational Therapy Driving Intervention for Returning Combat Veterans.
|
N/A | |
Completed |
NCT02765672 -
Effectiveness of a Driving Intervention on Safe Community Mobility for Returning Combat Veterans
|
N/A | |
Not yet recruiting |
NCT06335407 -
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
|
Phase 1 |